Ignite Creation Date:
2025-12-24 @ 4:59 PM
Ignite Modification Date:
2025-12-30 @ 6:46 PM
Study NCT ID:
NCT05073250
Status:
UNKNOWN
Last Update Posted:
2023-05-12
First Post:
2021-10-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
IBI376 Plus Rituximab in Patients With Untreated Indolent Lymphoma.
Sponsor:
Chinese PLA General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-31
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-11-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-10-08
First Submit QC Date:
None
Study First Post Date:
2021-10-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-11
Last Update Post Date:
2023-05-12
Last Update Post Date Type:
ACTUAL